Clinical Trial Update: Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial of perioperative MVT-5873, a CA 19-9 epitope–targeting monoclonal antibody, in operable CA 19-9–producing pancreatic cancers, cholangiocarcinomas,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Colon Cancer
• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• MVT-5873 (MVT-5873)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colon Cancer, Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-03-21